Asthma
Asthma RFs
Triggers
Occupational
Asthma Px
Asthma Ix
Measure eosinophil count or fractional nitric oxide (FeNO)
Diagnose asthma, without further investigations if:
Eosinophil is above reference range
FeNO is ≥ 50 ppb
If asthma is not confirmed by the eosinophil count or FeNO
measure bronchodilator reversibility (BDR) with spirometry
diagnose asthma if:
the FEV1 increase is ≥ 12% and 200 ml or more from the pre-bronchodilator measurement, or
the FEV1 increase is ≥ 10% of the predicted normal FEV1
if spirometry is not available or it is delayed, measure peak expiratory flow (PEF) twice daily for 2 weeks
diagnose asthma if:
PEF variability (expressed as amplitude percentage mean) is ≥ 20%
If asthma is not confirmed by eosinophil count, FeNO, BDR or PEF variability but still suspected on clinical grounds:
refer for consideration of a bronchial challenge test
diagnose asthma if bronchial hyper-responsiveness is present
Asthma Dx
Initial Ix
If dx uncertain
If still uncertain
Asthma new joint guidelines
Step 1: a low-dose inhaled cordicosteroid (ICS)/formoterol inhaler to be taken as needed for symptom relief (anti-inflammatory reliever (AIR) therappy
If the patients presents highly symptomatic or with a severe exacerbatiion-
Start treatment with low-dose MART
Treat the acute symptoms as appropriate (a course of oral corticosteroids may be indicated)
Step 2:
A low dose MART- (ICS/formoterol combination for maintenance therpay as needed ie regularly and as required)
Step 3:
A moderate-dose MART
Step 4:
Check the fractional exhaled nitric oxide (FeNO) level if available, and the blood eosinophil count-
If either raised- specialist case
If neither raised- trial LTRA or a LAMA in addition to MART
If control has not improved stop LTRA or LAMA and start the alternative (LTRA or LAMA)
Step 5-
Reder people to a specialist in asthma care when asthma is not controlled despite treatment with moderate-dose MART, and trials of an LTRA and a LAMA
Asthma further Mx
Asthma drugs
SABA - salbutamol
LABA - salmeterol, formoterol
SAMA - ipratropium
LAMA - tiotropium
ICS - beclometasone / budesonide
MART - Fostair - beclometasone + formoterol
Trimbow - beclometasone + formoterol + glycopyrronium
LTRA - montelukast
Theophylline
Acute exacerbation of asthma
Acute asthma Px
Acute asthma grading
Moderate
Acute severe
Life-threatening
(Near fatal)
Acute asthma Ix
Acute asthma admit if
Acute asthma Mx
Acute asthma criteria for discharge
COPD
Causes
COPD Patho
COPD Px
MRC SOB scale
COPD vs asthma
COPD Ix
COPD severity
Stage 1 / mild - FEV1>80%
Stage 2 / moderate - FEV1 50-79%
Stage 3 / severe - FEV1 30-49%
Stage 4 - very severe - FEV1 <30%
COPD Mx
COPD Inhaler Mx
1st step
2nd step
Asthma/steroid-responsive features
3rd step